Detection of cocaine and its metabolites in amniotic fluid and umbilical cord tissue

Journal of Analytical Toxicology

Volumn 21, Issue 2, 1997, Pages 97-104

  Winecker, Ruth E ^a   Goldberger, Bruce A ^a   Tebbett, Ian ^b   Behnke, Marylou ^a   Eyler, Fonda Davis ^a   Conlon, Michael ^a   Wobie, Kathy ^a   Karlix, Janet ^b   Bertholf, Roger L ^c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOYLECGONINE; COCAINE; ECGONINE METHYL ESTER; NORCOCAINE;

ADULT; AMNION FLUID ANALYSIS; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG TISSUE LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; PRENATAL DRUG EXPOSURE; SOLID PHASE EXTRACTION; UMBILICAL CORD;

EID: 0030894475     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/21.2.97     Document Type: Article

References (25)

1. G. Burkett, S.Y. Yasin, D. Palow, L. LaVoie, and M. Martinez. Patterns of cocaine binging: Effect on pregnancy. Am. J. Obstet. Gynecol. 171: 372-79 (1994).
2. C.H. Fox. Cocaine use in pregnancy. J. Am. Board Fam. Pract. 7: 225-28 (1994).
3. A.M. Dusick, R.F. Covert, M.D. Schreiber, G.T. Yee, S.P. Browne, C.M. Moore, and I.R. Tebbett. Risk of intercranial hemorrhage and other adverse outcomes after cocaine exposure in a cohort of 323 very low birth weight infants. J. Pediatr. 122: 438-45 (1993).
4. M.S. Gold. Cocaine, Drugs of Abuse: A Comprehensive Series for Clinicians. Vol. 3. Plenum Publishing, New York, NY, 1993, pp 1-79.
5. G. Das. Cocaine abuse and reproduction. Int. J. Clin. Pharm. Ther. 32: 7-11 (1994).
6. T.E. Yap, D. Diana, V. Herson, L. Chameides, and J.C. Rowe. Fetal myocardial calcification associated with maternal cocaine use. Am. J. Perinat. 11: 179-83 (1994).
7. J. Ho, E. Afshani, and F.B. Stapleton. Renal vascular abnormalities associated with prenatal cocaine exposure. Clin. Pediatr. 21: 155-56 (1994).
8. B.H. Brouhard. Cocaine ingestion and abnormalities of the urinary tract. Clin. Pediatr. 21: 157-58 (1994).
9. J.M. Dicke, D.K. Verges, and K.L. Polakoski. The effects of cocaine on neutral amino acid uptake by human placental basal membrane vesicles. Am. J. Obstet. Gynecol. 171: 485-91 (1994).
10. I.J. Chasnoff, C.E. Hunt, R. Kletter, and D. Kaplan. Prenatal cocaine exposure is associated with respiratory pattern abnormalities. Am. J. Dis. Child. 143: 583-87 (1989).
11. S.L.D. Ward, D. Bautista, L. Chan, M. Derry, A. Lisbin, M.J. Durfee, K.S.C. Mills, and T.G. Keens. Sudden infant death syndrome in infants of substance-abusing mothers. J. Pediatr. 117: 876-81 (1990).
12. E.M. Ostrea, M. Brady, S. Gause, A.L. Raymundo, and M. Stevens. Drug screening of newborns by meconium analysis: A largescale prospective, epidemiologic study. Pediatr. 89: 107-13 (1992).
13. O.Q. Casanova, N. Lombardero, M. Behnke, F.D. Eyler, M. Conlon, and R.L. Bertholf. Detection of cocaine exposure in the neonate: Analyses of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine. Arch. Pathol. Lab. Med. 118: 988-93 (1994).
14. P.R. Mahone, K. Scott, G. Sleggs, T. D'Antoni, and J.R. Woods. Cocaine and metabolites in amniotic fluid may prolong fetal drug exposure. Am. J. Obstet. Gynecol. 171: 465-69 (1994).
15. L. Jain, W. Meyer, C. Moore, I. Tebbett, D. Gauthier, and D. Vidyasagar. Detection of fetal cocaine exposure by analysis of amniotic fluid. Obstet. Gynecol. 81: 787-90 (1993).
16. C.M. Moore, S. Brown, A. Negrusz, I. Tebbett, W. Meyer, and L. Jain. Determination of cocaine and its major metabolite, benzoylecgonine, in amniotic fluid, umbilical cord blood, umbilical cord tissue, and neonatal urine: A case study. J. Anal. Toxicol. 17: 62 (1993).
17. N. Lombardero, O. Casanova, M. Behnke, F.D. Eyler, and R.L. Bertholf. Measurement of cocaine and metabolites in urine, meconium, and diapers by gas chromatography/mass spectrometry. Ann. Clin. Lab. Sci. 23: 385-94 (1993).
18. E.J. Cone, M. Hillsgrove, and W.D. Darwin. Simultaneous measurement of cocaine, cocaethylene, their metabolites, and "crack" pyrolysis products by gas chromatography-mass spectrometry. Clin. Chem. 40: 1299-1305 (1994).
19. D.A. Frank, B.S. Zuckerman, H. Amaro, K. Aboagye, H. Bauchner, H. Cabral, L. Fried, R. Hingson, H. Kayne, S.M. Levenson, S. Parker, H. Reece, and R. Vinci. Cocaine use during pregnancy: Prevalence and correlates. Pediatrics 82: 888-95 (1988).
20. K.L. Moore and T.V.N. Persaud. The Developing Human: Clinically Orientated Embryology. 5th ed. W.B. Saunders, Philadelphia, PA, 1993.
21. R.A. Brace. Amniotic fluid dynamics. In Maternal-Fetal Medicine, Principals and Practice. R.K. Creasy and R. Resnilk, Eds. 3rd ed. W.B. Saunders, Philadelphia, PA, 1994, pp 106-11.
22. M.G. Ripple, B.A. Goldberger, Y.H. Caplan, M.G. Blitzer, and S. Schwartz. Detection of cocaine and its metabolites in human amniotic fluid. J. Anal. Toxicol. 16: 328-31 (1992).
23. C. Moore, S. Browne, I. Tebbett, A. Negrusz, W. Meyer, and L. Jain. Determination of cocaine and benzoylecgonine in human amniotic fluid using flow solid-phase extraction columns and HPLC. Forensic Sci. Int. 56: 177-81 (1992).
24. J.A. Madden and R.H. Powers. Effect of cocaine and cocaine metabolites on cerebral arteries in vitro. Life Sci. 47: 1109-14 (1990).
25. B.A. Erickson, R.J. Konkol, and J.A. Madden. A comparison of the epileptogenic potential of cocaine and benzoylecgonine following intraventricular administration in nonanesthetized rats. FASEB J. 4: 746A (1990).